BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoingPublic.de - ECPv6.16.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.goingpublic.de
X-WR-CALDESC:Veranstaltungen für GoingPublic.de
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260209T100000
DTEND;TZID=Europe/Berlin:20260211T160000
DTSTAMP:20251210T075928Z
CREATED:20251201T092701Z
LAST-MODIFIED:20251210T075928Z
UID:156160-1770631200-1770825600@www.goingpublic.de
SUMMARY:Handelsblatt Jahrestagung „Pharma“
DESCRIPTION:Technologische Innovationen\, regulatorische Reformen\, globale Unsicherheiten\, Finanzierungsdruck\, Versorgungslücken und neue Digitalisierungsstrategien. Die Pharmabranche verändert sich grundlegend. Auf der Handelsblatt Jahrestagung Pharma 2026 gehen wir diesen Dynamiken auf den Grund und erörtern die Auswirkungen auf Investitionen\, Produktion und die Zukunft der Versorgung. \n Themenfokus: \n\nAI in Pharma – Von Molekül bis Markt\nWettbewerbsstandort Europa – Chancen\, Risiken\, Zukunft\n AMNOG 2.0 – Zulassung und Preisfindung im Wandel\n\nDie Speaker (u.a.): \n\nChristiane Bardroff\, COO – Rentschler Biopharma\nChantal Friebertshäuser\, Senior Vice President Europe\, Middle-East and international tenders – Moderna\nDr. Benjamin Gmeiner\, Director Medical Data Strategy & Science – Novartis Deutschland\nDr. Antje Haas\, Abteilungsleiterin\, Arznei- und Heilmittel – GKV-Spitzenverband\nHeidrun Irschik-Hadjieff\, Vorsitzende der Geschäftsführung – Sanofi\nThomas Müller\, Leiter der Abteilung 1 „Arzneimittel\, Medizinprodukte und Biotechnologie“ – Bundesministerium für Gesundheit\n Dr. Daniel Steiners\, Vorstand – Roche Pharma AGMehr Informationen\nThomas Weigold\, Country President Sandoz Germany & CEO – Hexal\n\nWeitere Informationen unter: https://live.handelsblatt.com/event/jahrestagung-pharma/?utm_medium=ko&utm_source=76&utm_campaign=P1201167&utm_content=email&utm_term=GP \nRabattcode: 76D2502058LS
URL:https://www.goingpublic.de/event/handelsblatt-jahrestagung-pharma-2/
LOCATION:Berlin Pullman Schweizerhof Budapester Str. 25 10787 Berlin\, Budapester Str. 25\, Berlin\, 10787\, Germany
CATEGORIES:Life Sciences
ATTACH;FMTTYPE=image/jpeg:https://www.goingpublic.de/wp-content/uploads/2025/12/p1201167-banner-600x200px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260210T140000
DTEND;TZID=Europe/Berlin:20260210T200000
DTSTAMP:20260122T155608Z
CREATED:20260121T155027Z
LAST-MODIFIED:20260122T155608Z
UID:157487-1770732000-1770753600@www.goingpublic.de
SUMMARY:AI4Biotech: Meet the Experts – Hey Chat\, what’s next in Biotech and Medicine?
DESCRIPTION:*** Agenda now online *** Following up on its successful kickoff in November 2025\, the AI4Biotech: Meet the Experts series continues! The “Meet the Experts” event brings together key players from the fields of biotechnology and artificial intelligence for an intensive afternoon of knowledge exchange\, practical insights\, and networking. \n  \nThe event is co-organized by Adrian Passow (Omegametrix) and Sabine Hauck (Dequra). \nConfirmed talks: \n\n\nProf. Dr. Björn Eskofier\, Head of Institute for AI in Medicine (I-AIM)\, Ludwig-         Maximilians-Universität München\nDr. Kei Müller\, CEO & Co-Founder\, Ebenbuild GmbH\nDr. Mareike Albert\, Founder & CSO\, Noselab GmbH\nProf. Dr. Lukas Milles\, Professor and Group Leader at Gene Center\, Ludwig-Maximilians-Universität München & Max Planck Institute of Biochemistry\nDr. Patrick Grossmann\, CEO & Co-Founder\, Invitris GmbH\nDr. Adrian Schomburg\, CEO & Founder\, Eisbach Bio GmbH\n\n\nFind here the full agenda for AI4Biotech: Meet the Experts – “Hey Chat\, what’s next in Biotech and Medicine?” \nExperience how AI is transforming biotech and medicine and connect with the AI4Biotech community. \n\n\nWe invite everyone who is interested in the future of biotechnology and medicine with artificial intelligence – whether you’re part of an established company\, an innovative start-up\, a pre-seed team\, a researcher\, or a technology provider. \nJoin us for an inspiring afternoon of networking\, exchanging ideas\, and exploring the latest real-world applications of AI in biotech and medicine. \nParticipation is free\, but registration is required.\nRegistration
URL:https://www.goingpublic.de/event/ai4biotech-meet-the-experts-hey-chat-whats-next-in-biotech-and-medicine/
LOCATION:Max Planck Institute of Biochemistry\, Am Klopferspitz 18\, Martiensried\, 82152
CATEGORIES:Life Sciences
ATTACH;FMTTYPE=image/jpeg:https://www.goingpublic.de/wp-content/uploads/2026/01/Banner-meet-the-experts_26_640x320_-e1769097356179.jpg
ORGANIZER;CN="BioM Biotech Cluster Development GmbH":MAILTO:info@bio-m.org
END:VEVENT
END:VCALENDAR